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Abstract: The marine genus Pseudoalteromonas is known for its versatile biotechnological potential
with respect to the production of antimicrobials and enzymes of industrial interest. We have
sequenced the genomes of three Pseudoalteromonas sp. strains isolated from different deep sea sponges
on the Illumina MiSeq platform. The isolates have been screened for various industrially important
enzymes and comparative genomics has been applied to investigate potential relationships between
the isolates and their host organisms, while comparing them to free-living Pseudoalteromonas spp. from
shallow and deep sea environments. The genomes of the sponge associated Pseudoalteromonas strains
contained much lower levels of potential eukaryotic-like proteins which are known to be enriched
in symbiotic sponge associated microorganisms, than might be expected for true sponge symbionts.
While all the Pseudoalteromonas shared a large distinct subset of genes, nonetheless the number of
unique and accessory genes is quite large and defines the pan-genome as open. Enzymatic screens
indicate that a vast array of enzyme activities is expressed by the isolates, including β-galactosidase,
β-glucosidase, and protease activities. A β-glucosidase gene from one of the Pseudoalteromonas
isolates, strain EB27 was heterologously expressed in Escherichia coli and, following biochemical
characterization, the recombinant enzyme was found to be cold-adapted, thermolabile, halotolerant,
and alkaline active.
Keywords: Pseudoalteromonas; enzymes; genomics; pan-genome
1. Introduction
The genus Pseudoalteromonas are a subgroup of Gram-negative Gammaproteobacteria with
common features, including a requirement for Na+ ions, motility, and aerobic and chemoheterotrophic
metabolism. The genus was first described by Gauthier and co-workers and separated from the
genus Alteromonas [1]. The genus can be divided into either pigmented or non-pigmented species,
with members of the genus being known to possess the ability to produce a wide array of bioactive
compounds. The pigmented species, in particular, are known to produce a range of antimicrobial and
antifouling compounds which display activity against a broad spectrum of organisms and have, as a
result, been widely investigated in the past [2–5]. While the non-pigmented species are typically not
antimicrobial producers, they are, however, versatile producers of an array of different extracellular
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enzymes that are of potential biotechnological interest [6–10]. Pseudoalteromonas are one of the most
frequently isolated bacteria from marine environments [11] and are routinely found in association
with various eukaryotic hosts in these environments such as tunicates [12], algae [13], sponges [14],
mussels [15], pufferfish [16], as well as algae and marine plants [17,18]. They have also been isolated
as free living in seawater [19], sea ice [20], and marine sediment [21].
The deep oceans as an ecosystem are of growing interest to the scientific community. While the
mean depth of the oceans is 3800 m, about 50% is deeper than 3000 m. With only 5% of the ‘deep sea’
having been explored to date, it is clear that the biotechnological potential of this unique ecosystem
has yet to be fully exploited [22–24]. We have previously reported on the microbial biodiversity
of deep sea sponges sampled at depths of between 760 and 2900 m below sea level, indicating
that the microbial community structures of these sponges may represent an untapped source of
potential microbial biodiversity [25,26]. Bacterial and fungal communities from deep sea sediments
also continue to receive attention, not only from an ecological standpoint [27], but also due to the
ability of microorganisms isolated from this ecosystem to produce novel bioactive molecules [28,29] and
enzymes of biotechnological importance [30,31]. Cold-active enzymes are of particular interest as they
possess a range of structural features that promote flexibility at the active site, low substrate affinity, and
high specific activity at low temperatures. These characteristics are important in industrial biocatalysis,
not only from an energy savings standpoint, but also due to the fact that performing reactions at low
temperatures prevents undesirable chemical side reactions which can occur at higher temperatures; while
also allowing rapid thermal inactivation of these enzymes, due to their thermolabile properties [32,33].
Pseudoalteromonas strains have previously been reported to produce a number of cold adapted
enzymes including DNA ligase [34,35], pectate lyase [36], β-galactosidase [6], subtilase [10],
and agarase [9], with enzyme production in Pseudoalteromonas haloplanktis TAC125 and other
Pseudoalteromonas strains namely sp. ANT506, sp. ANT178, sp. KMM701, and sp. CF6-2 in
particular being studied in more detail [31,33]. The cold adaptation properties of Pseudoalteromonas
haloplanktis TAC125 have been described with respect to its thioredoxin system [37,38] and the
involvement of a single highly-active iron superoxide dismutase as a reactive oxygen species defense
mechanism [39,40]. With this in mind, this study focused on the isolation and comparative genomics
of three non-pigmented Pseudoalteromonas spp. isolated at different depths from both marine sponges
and sediment in an effort to assess their biotechnological potential.
The genomes share a large pan-genome and have a considerable number of unique gene clusters,
but only a small number of genes are associated with potential host interaction in all the investigated
genomes, irrespective of whether or not they have been isolated from sponges, from deep sea sediment,
or from ocean water. Furthermore, Pseudoalteromonas strains EB27, SK18, and SK20, isolated from
deep sea sponges do not share a large number of genes that could be attributed to a symbiotic
lifestyle. While the strains displayed cold-adapted growth characteristics, they are unlikely to be
true psychrophiles. The three strains did however display a number of interesting enzyme activities
including β-glucosidase, protease, and β-galactosidase activities and a heterologously expressed
β-glucosidase from strain EB27 displayed properties that are favorable to industrial applications, such
as alkaline pH optimum, halotolerance, and cold-adaptation.
2. Results
2.1. Enzymatic Activity Profile
The three Pseudoalteromonas spp. isolates displayed a range of different enzyme activity profiles
(Table 1) in plate based screening assays. The Poecillastra compressa isolate EB27 (retrieved from a
depth of 1480 m) displayed the greatest range of different activities, with the most prominent being
β-glucosidase, protease, and cellulase activity. SK20 (Inflatella pellicula, 2900 m) exhibited strong
β-galactosidase activity and SK18 (Sericolophus hawaiicus, 2129 m) displayed high levels of protease
activity. All of the isolates displayed some lipolytic activity.
Mar. Drugs 2017, 15, 184 3 of 17
Table 1. Enzyme active profile of the Pseudoalteromonas sp. isolates based on plate screenings. Activity
is depicted as ‘X’ and intensity is indicated by the number of ‘Xs’, with ‘X’ low activity and ‘XXX’
describing highest activity. (Glc = β-glucosidase, Gal = β-galactosidase).
Isolate ID Sponge Depth (m) Cellulase Lipase Protease β-Glc/Gal
EB27 Poecillastra compressa 1480 XX X XXX XXX (Glc)
SK18 Sericolophus hawaiicus 2129 - X XXX -
SK20 Inflatella pellicula 2900 - X - XXX (Gal)
Semi-quantitative assays investigating protease (SK18, EB27) and β-galactosidase (SK20, EB27)
activity were also performed (Supplementary Figure S1); however, these activities do not appear to be
cold adapted.
To assess the general temperature–growth profile of the three isolates we performed growth
experiments at different temperatures (4 ◦C, 23 ◦C, 28 ◦C, and 37 ◦C) and calculated the growth rate
and doubling time (Table 2).
Table 2. Growth characteristics (specific growth rate and generation time) of the Pseudoalteromonas
sponge isolates at different temperatures (n = 3), including standard errors. Mu (specific growth rate) =










EB27 0.54 ± 0.15; 88.3 ± 20.01 1.03 ± 0.05; 40.6 ± 2.1 0.98 ± 0.04; 42.46 ± 1.84 0.82 ± 0.09; 51.39 ± 6.75
SK18 0.28 ± 0.06; 159.36 ± 12.75 1.76 ± 0.095; 23.8 ± 1.24 2.08 ± 0.013; 20 ± 0.13 1.46 ± 0.16; 29.04 ± 2.9
SK20 0.29 ± 0.02; 144.92 ± 31.2 0.99 ± 0.08; 42.36 ± 3.56 1.41 ± 0.01; 29.5 ± 0.24 0.9 ± 0.14; 48.66 ± 7.29
We decided to sequence the genomes of these three Pseudoalteromonas strains in an attempt to gain
a better understanding of their biotechnological potential based on these preliminary extracellular
enzyme profiles, together with the fact that other Pseudoalteromonas strains such as Pseudoalteromonas
haloplanktis strains TAC125, TAE79, Sp22b, and AS-11 have all been shown to produce a large
number of biotechnologically important biocatalysts [41]. In addition, representatives of the genus
Pseudoalteromonas have also been shown to produce a broad array of bioactive molecules such as
antibiotics, antitumor agents, and toxins/antitoxins [11,42–45].
2.2. Genome Sequencing and Assembly
The three Pseudoalteromonas genomes were sequenced on the MiSeq platform and the coverage
obtained ranged from 196× to 230×. The number of identified coding DNA sequences (CDS) ranged
from 3582 to 4012, with EB27 having the largest genome of 4.56 Mb and 4012 CDS and SK18 the
smallest genome with 3.98 Mb and 3582 CDS (Table 3). The sequencing results fall within the size
range of known Pseudoalteromonas spp. genomes (Pseudoalteromonas haloplanktis TAC125 3.85 Mb [46]
to Pseudoalteromonas atlantica T6c 5.1 Mb [47,48]), and do not appear to display any unusual patterns
which may relate to their host sponge origin, like genome size or differing GC content. Nonetheless,
the genome of EB27 is approximately 10% larger than the other compared genomes.
Table 3. Genome sequencing statistics and genome features of reference strains. (CDS, coding DNA










TAC125 3.85 40.1% n/a n/a 3473 134 n/a 100
SM9913 4.04 40.3% n/a n/a 3699 87 n/a 100
EB27 4.56 39.1% 216.9 114 4012 136 196× 99.72
SK18 3.98 40.2% 156.5 115 3582 110 213× 99.75
SK20 4.15 40.3% 98.5 213 3811 139 230× 99.66
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2.3. Genome Comparison
The Bacterial Pan Genome Analysis (BPGA) pan-genome pipeline was used to compare the whole
genome sequences (Figure 1) [49]. Pseudoalteromonas haloplanktis TAC125 was used as a reference strain
representing a shallow water isolate and Pseudoalteromonas sp. SM9913 was used as a deep sea reference
strain as it had been retrieved from a deep sea sediment sample (1855 m) [21,46]. A phylogenetic
comparison of the 16S rRNA gene of the isolates, reference strains, and a number of relevant type strains
defined our isolates as true Pseudoalteromonas spp. (Figure 2). The 16S rRNA genes from the reference
strains used for the whole genome comparison in this study were identified from the respective
genomes by RNAmmer [50]. Due to the not fully assembled genomes (only one 16S rRNA copy in
SK18 and EB27) of the isolates SK18, SK20, and EB27, the 16S rRNA gene sequences were retrieved by
PCR. A pan-genome analysis, based on the comparison of all translated protein sequences, was then
performed. The number of translated protein sequences present ranged from 3422 for Pseudoalteromonas
haloplanktis TAC125 to 3941 for Pseudoalteromonas sp. EB27, with 2482 of these proteins being orthologs;
making up 72.5% of the smallest genome and 62.9% of the largest genome. The number of unique
proteins or paralogs is quite large, ranging from 308 to 809. The sponge isolates share 10 protein
clusters not found in the free-living reference strains TAC125 and SM9913. These clusters include
genes potentially encoding cation efflux proteins, integrases, recombinases, and proteins potentially
involved in multidrug resistance and which may play a role in helping the Pseudoalteromonas strains
adapt to life inside the sponge, and in helping them cope with other microorganisms inhabiting the
sponge. For example, recombinases and integrases are known to mediate horizontal gene transfer,
which is believed to play a key role in the genomic evolution of symbionts [51]. When comparing the
individual isolates to the reference strains, EB27 shared 183 clusters with TAC125 and only 28 with
SM9913, while SK18 shared 14 clusters with TAC125 and 75 clusters with SM9913. In addition, SK20
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Figure  1. Whole genome  comparison of  translated non‐redundant protein  clusters  from  all  three 
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widespread  and  affiliated  with  many  different  cellular  functions  such  as  signal  transduction 
mechanisms, cell wall, membrane and envelope biogenesis,  recombination and  repair, and many 
with only general or unknown function; so that no obvious pattern is evident. The accessory genes 
Figure 1. hole genome comparison of translated non-redundant protein clusters from all three
isolates and the two reference geno es (generated with [52]). Green coloured is Pseudoalteromonas
haloplanktis TAC125, blue coloured Pseudoalteromonas sp. SM9913, light red coloured is SK18, yellow
coloured is SK20 and orange coloured is EB27.
The distribution of the protein clusters of orthologous groups (COG) affiliated with biological
functions can be seen in Figure 3 (generated with [49]). The unique genes as mentioned earlier make
up in total approximately 8.5 to 20% per genome. The potential function of these genes appears
to be widespread and affiliated with many different cellular functions such as signal transduction
mechanisms, cell wall, membrane and envelope biogenesis, recombination and repair, and many
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with only general or unknown function; so that no obvious pattern is evident. The accessory genes
appear to be affiliated with several functions such as signal transduction mechanisms and defense
mechanisms, and proteins with either an as yet unknown function or only a general prediction, but
with again no obvious links with a specific function. The core genome mainly contributes towards
cell cycle control, cell division, chromosome partitioning, translation, ribosomal structure, biogenesis,
and nucleotide transport and metabolism (Figure 3). According to the COG distribution the Kyoto
Encyclopedia of Genes and Genomes (KEGG) distribution of the translated genomes can be found in

















Figure 2. Phylogenetic comparison of the isolates investigated and reference strains (marked in red
are the isolates that are used for this study. Maximum likelihood bootstrap consensus tree from
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of the five investigated Pseudoalteromonas genomes (generated with [49]). Figure 3. Cluster of orthologous groups (COG) distribution of the core, accessory, and unique genes ofthe five investigated Pseudoalteromonas genomes (generated with [49]).
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The pan-genome analysis revealed an open pan-genome for the five Pseudoalteromonas isolates
investigated here. Therefore, the number of dispensable or accessory genes is orders of magnitude
larger than the size of the core genome and increases with the number of additional genomes
(Figure 4), as defined by [56]. For the five genomes, the pan genome contains 6077 genes and the
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TAC125  49  0  35  0  2 
SM9913  67  0  42  2  3 
EB27  69  1  48  4  5 
SK18  63  0  39  2  3 
SK20  56  1  40  2  3 
EB27  contained  two  genes  encoding periplasmic  β‐glucosidases  and  two  genes which were 
annotated  solely  as  β‐glucosidases.  The  two  β‐glucosidase  annotated  genes were  similar  in  size   
Figure 4. Core vs. pan-genome size plot generated with Bacterial Pan Genome Analysis BPGA tool [49].
The genome equenc s were then manually screened for genes encoding enzymes of potential
industrial interest and were found to be quite rich in potential lipases/esterases and proteases, and
to contain a relatively small number of potential β-galactosidase, β-glucosidase, and cellulase genes
(Table 4). The number of potential genes encoding these enzyme activities does not, however, reflect
the phenotypes seen in the plate screening assays (Table 1). For example, the presence of β-glucosidase
genes does not necessarily lead to a positive phenotypic assay for this enzyme activity; all investigated
Pseudoalteromonas strains contain at least two β-glucosidase genes, except for TAC125 which hosts
none, but only EB27 displays this enzyme active in the plate screenings. However, the increased
number of potential β-glucosidase- and cellulase-encoding genes in the genome of EB27 may account
for the positive screening results in th plate assays for these enzyme activities.
Table 4. Abundance of genes encoding for enzymes of potential industrial interest.
ID Lipase/Est. β-Galactosidase Protease β-Glucosidase Cellulase
TAC125 49 0 35 0 2
M9913 67 0 42 2 3
EB27 69 1 48 4 5
SK18 63 0 39 2 3
SK20 56 1 40 2 3
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EB27 contained two genes encoding periplasmic β-glucosidases and two genes which were
annotated solely as β-glucosidases. The two β-glucosidase annotated genes were similar in size
(1329 bp, 443 aa) and shared 72% nucleotide and 71% protein identity. Based on the strong
β-glucosidase activity observed in EB27, one of the two β-glucosidase genes was cloned using PCR and
subsequently subcloned into the Escherichia coli heterologous expression system. Following purification
of the recombinant β-glucosidase, initial biochemical characterisation experiments investigating
optimal temperature, temperature stability, pH dependency, and halotolerance were conducted to
assess its potential for industrial applications (Figure 5). The heterologously expressed β-glucosidase
from EB27 was most active at pH 7.6 with optimal temperatures ranging from 28 ◦C to 37 ◦C.
Good activity was also observed at 4 ◦C, 23 ◦C, and 45 ◦C. The enzyme was found to be quite
thermolabile, losing 90% of its activity following incubation at 37 ◦C for 30 min (Figure 5). The optimal
temperature profile and the observed thermostability of the β-glucosidase would indicate that the
enzyme is psychrophilic, being active at low temperatures, but readily inactivated at slightly elevated
temperatures (28 ◦C and above). The halotolerance of the enzyme was assessed at various salt
concentrations ranging from 2 to 14% sodium chloride. The enzyme loses approximately 25% of its
activity in the 2 to 8% salt concentration range, with further decreases in activity being observed
at higher salt concentrations (Figure 5). The recombinant enzyme would, therefore, appear to be
halotolerant rather than halophilic.
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strains. The  isolates were grown on both  low  and  rich nutrient media  and  then overlaid with  a 
number of clinically relevant test strains such as Escherichia coli 12210, Staphylococcus aureus NCD0 
949,  Bacillus  subtilis  1E32,  Pseudomonas  aeruginosa  PA‐O1,  Acinetobacter  johnsonii  WH00185, 
Enterobacter  faecium NCIMB  11508, Klebsiella  pneumonia NCIMB  13218,  and  Enterobacter  aerogenes 
NCIMB  10102  in  soft  LB‐agar.  No  bioactivity  was  observed,  despite  the  fact  that  all  three 
Pseudoalteromonas genomes contained at least one potential bacteriocin gene cluster (EB27 contained 
two  bacteriocin  gene  clusters),  with  SK18  and  EB27  also  containing  potential  arylpolyene  and 
siderophore encoding gene cluster (Table 5). 
Figure 5. Optimal temperature (a), temperature stability (b), pH dependency (c) and halotolerance
(d) assay results of a heterologously expressed β-glucosidase from the Pseudoalteromonas sp. EB27.
The highest activity per assay was set as 100% activity and the other values were calculated accordingly.
The highest total activity was measured as 2.5 U/mg of β-glucosidase at pH 7.6 and 28 ◦C.
Deferred antagonism-based antimicrobial assays were also performed in an effort to determine
whether the three Pseudoalteromonas strains displayed any bioactivity against clinically-relevant test
strains. The isolates were grown on both low and rich nutrient media and then overlaid with a
number of clinically relevant test strains such as Escherichia coli 12210, Staphylococcus aureus NCD0
949, Bacillus subtilis 1E32, Pseudomonas aeruginosa PA-O1, Acinetobacter johnsonii WH00185, Enterobacter
faecium NCIMB 11508, Klebsiella pneumonia NCIMB 13218, and Enterobacter aerogenes NCIMB 10102 in
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soft LB-agar. No bioactivity was observed, despite the fact that all three Pseudoalteromonas genomes
contained at least one potential bacteriocin gene cluster (EB27 contained two bacteriocin gene clusters),
with SK18 and EB27 also containing potential arylpolyene and siderophore encoding gene cluster
(Table 5).
Table 5. Abundance of secondary metabolite gene clusters.
ID Bacteriocin Arylpolyene Siderophore
TAC125 1 1 -
SM9913 1 - 1
EB27 2 1 -
SK18 1 1 1
SK20 1 - -
In addition, when TAC125 and SM9913 were subsequently analysed, one potential bacteriocin
gene cluster was found to be present and highly conserved between the different isolates and the
reference genomes (Figure 6). This gene cluster consists of 13 different genes with an average total
size of 10.8 kb, except in SK20, in which the cluster only consists of seven genes with a total of 6.1 kb
(Figure 6). In addition to the conserved bacteriocin gene cluster that can be found in all isolates, EB27
has a second small bacteriocin gene cluster spanning 10 kb, which is considerably different than the
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Given  that  these  Pseudoalteromonas  spp.  had  been  isolated  from  different  sources,  such  as 
sponges (EB27, SK18, SK20), deep sea sediment (SM9913), as well as from open Antarctic seawater, 
we decided to investigate the presence of potential eukaryotic‐like proteins such as ankyrin‐repeats 
(ANK)  and  tetratricopeptide  repeats  domain‐encoding  proteins  (TRP)  which  are  known  to  be 
enriched in symbiotic sponge‐associated microorganisms [60] (Table 6). The genomes of all isolates 
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Reductase  Proteases  Sulfatases  Peptidases 
TAC125  2  2  1  35  0  58 
SM9913  1  2  0  42  1  63 
EB27  2  2  3  48  0  65 
SK18  1  2  0  39  1  63 
SK20  1  2  0  40  1  58 
Figure 6. Organisation of the Bacteriocin gene clusters found in the investigated geno es (adapted
fro antiSMASH [57–59]). Red coloured genes are biosynthetic genes, blue colour d transport-related
gene , g een coloured regulatory genes and grey colour d other/unidentified genes. The red arrow
poi t add the gene containing a tetratricopeptide repeat.
Given that these Pseudoalteromonas spp. had been isolated from different sources, such as sponges
(EB27, SK18, SK20), deep sea sediment (SM9913), as well as from open Antarctic seawater, we decided
to investigate the presence of potential eukaryotic-like proteins such as ankyrin-repeats (ANK) and
tetratricopeptide repeats domain-encoding proteins (TRP) which are known to be enriched in symbiotic
sponge-associated microorganisms [60] (Table 6). The genomes of all isolates were found to contain a
small number of genes with ankyrin and tetratricopeptide repeats, which are present at much lower
levels than might be expected from a true sponge symbiont, such as Poribacteria sp. which contain at
least 23 genes with tetratricopeptides repeats in its genome [61].
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Reductase Proteases Sulfatases Peptidases
TAC125 2 2 1 35 0 58
SM9913 1 2 0 42 1 63
EB27 2 2 3 48 0 65
SK18 1 2 0 39 1 63
SK20 1 2 0 40 1 58
3. Discussion
Pseudoalteromonas spp. are known to be multitalented with respect to the production of enzymes
of industrial interest; for example agarases [9], galactosidases [6], proteases [62], subtilases [10], and
phospholipases [8] have been described from this genus. Furthermore some isolates are also able
to produce acidic exopolysaccharides involved in biofilm formation [63], as well as antimicrobial
compounds [64,65]. In general, the Pseudoalteromonas genus can be divided into pigmented and
non-pigmented species, with the former producing mostly antimicrobial and antifouling compounds,
and the latter being more versatile in the production of different enzymes [3]. The Pseudoalteromonas
spp. isolates described herein are naturally non-pigmented and are, therefore, no exception to the
aforementioned general classification as they produce a variety of different enzymes, but display no
antimicrobial activity under the assay conditions tested, but interestingly they do possess potential
bacteriocin and siderophore gene clusters in their genomes (Table 5, Figure 6).
Having isolated a number of Pseudoalteromonas strains from deep sea sponges, we decided to
employ a number of approaches including plate screening, whole genome sequencing, and comparative
genomics in an attempt to identify genes encoding enzymes with potentially biotechnologically
relevant properties. The isolates were found to be cold adapted rather than true psychrophiles,
according to the observed growth rates and doubling times at various temperatures (Table 2), and
expressed a number of different enzyme activities, including β-glucosidase, β-galactosidase, protease,
and lipase activities (Table 1). The isolates grew best at 23 ◦C and 28 ◦C with doubling times ranging
from 20 to 40 min, compared to a generation time of 20 min at 37 ◦C for the mesophilic E. coli K-12
strain MG1655 [66], which shows that our isolates are capable of achieving similar growth rates to
E. coli at these temperatures, supporting the feasibility of using Pseudoalteromonas as an expression
system for cold adapted enzymes as previously demonstrated by Papa and colleagues [67].
Good activity levels for the recombinant β-glucosidase enzyme were observed at temperatures
ranging from 4 ◦C to 37 ◦C, with optimal activity at 28 ◦C to 37 ◦C at a pH of 7.6 (Figure 5). Furthermore,
the β-glucosidase was quite thermolabile, losing 30% of its activity after 30 min of incubation at 28 ◦C
and 90% of its activity after 30 min of incubation at 37 ◦C. While β-glucosidases are typically involved
in important processes in bacteria, such as degradation of cellulose and other carbohydrates for
nutrient uptake, there is an increased interest in their use in the conversion of lignocellulosic biomass
into reducing sugars for ethanol production. While at least two other types of enzymes are also
required for the complete degradation of cellulose, namely the endoglucanases and cellobiohydrolases;
β-glucosidases are believed to be the rate-limiting enzyme in these processes [68]. They also find
industrial applications in wine making where they play a key role in the enzyme-mediated release of
aromatic compounds from glycosidic precursors present in fruit juices, musts, and fermenting products.
They are also used in flavour enhancement to improve the organoleptic properties of citrus fruit juices
to reduce bitterness [69]. While the majority of β-glucosidases currently in use are mostly fungal
in origin, bacterial derived enzymes are receiving increased recent interest, particularly for biofuel
production applications [69]. Furthermore, enzymes from Pseudoalteromonas have proven useful in the
hydrolysis of carbohydrates from algal biomass under alkaline conditions, which is uncommon for
terrestrial β-glucosidases and could be used for biofuel production from marine sources [69–71].
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As mentioned earlier, members of the genus Pseudoalteromonas are routinely isolated from a
variety of different marcoorganisms. While they have also been isolated from sea water and sediment,
they are usually found in association with macroorganisms [3,72]. With this in mind, we investigated
the genomes of our three deep sea sponge associated Pseudoalteromonas strains, together with two
free-living isolates for the presence of potential symbiosis genes, such as genes mediating microbe–host
interactions (genes containing eukaryotic-like domains, like ankyrin and tetratricopeptide repeats) or
those that may be beneficial in the acquisition or production of nutrients such as proteases, sulfatases
or peptidases for the host or the symbiont [61,73]. While the genomes of the sponge-associated and
free-living Pseudoalteromonas sp. isolates were rich in proteases and sulfatases, they lacked large
numbers of genes encoding potential ankyrin and tetratricopeptide repeats (Table 6). Interestingly
one of the genes which did contain a tetratricopeptide repeat is part of the conserved bacteriocin
gene cluster that is found in all isolates (Figure 6), which provides some limited evidence of potential
microbe–host interactions. In this respect, it is known that some bacteriocins are involved in mediating
microbe–host interactions via biofilm formation on which a host can settle [74]. However, the lack
of appreciable numbers of genes containing eukaryotic-like domains amongst the genomes of the of
Pseudoalteromonas sponge isolates appears to suggest that they may not in fact form a true symbiotic
relationship with their host. These Pseudoalteromonas isolates may, however, be indirectly beneficial
to the sponge by breaking down polysaccharides or other nutrient containing materials and thereby
making these available to both themselves and to the sponge; by functioning as either a commensal or
transiently associated microbe.
The pan-genome of the investigated isolates is open and each genome contains 8.5 to 20% unique
genes and the core genome comprises of 2482 genes (Figure 1), whereas the whole pan genome
comprises of 6077 genes. The possible functions of the translated genes have been investigated by
assigning them to clusters of orthologous function. The distribution of the unique, accessory, and
core genes is widespread across different biological functions and no obvious pattern is evident,
besides core functions that seem to be conserved in all genomes such as cell cycle control, cell division,
chromosome partitioning, translation, ribosomal structure, biogenesis, and nucleotide transport and
metabolism (Figure 3).
4. Conclusions
The following a comparative genomic analysis of non-pigmented sponge associated
Pseudoalteromonas sp. isolated from different depths and free-living Pseudoalteromonas sp. we
have demonstrated that these strains share a large open pan-genome and possess a considerable
number of unique genes which is in line with results of other genome comparison of non-pigmented
Pseudoalteromonas spp. [43]. We were unable to obtain definitive evidence based on these genome
comparisons that non-pigmented Pseudoalteromonas spp. form true symbiotic relationships with deep
sea sponges. While these non-pigmented strains do not appear to produce antimicrobial compounds,
they do, however, produce a wide variety of different degradative enzymes, such as proteases, lipases,
β-glucosidases, and β-galactosidases. A β-glucosidase gene was cloned from Pseudoalteromonas EB27
and heterologously expressed in Escherichia coli. Biochemical characterization of the recombinant
β-glucosidase enzyme revealed enzyme characteristics with potentially useful biotechnological
applications. For example, various food processing and bioremediation processes require halotolerant
enzymes [75], while cold-active enzymes find uses in food production, detergents and in molecular
biology [76]. There is also interest in the biotechnological application of β-glucosidases in relation
to plant-based foods, such as their use in the conversion of phytoestrogen glucosides in fruits and
vegetables to aglycone moieties and the removal of bitter compounds from citrus fruit juices [77].
The three Pseudoalteromonas sp. strains also possess good levels of extracellular lipase and protease
activity; two important classes of industrial enzymes with projected global markets set to reach
$590M USD and $2.21B USD by 2020 and 2021, respectively [78]. Alkaline proteases in particular
are important industrial enzymes with application in detergents. Production of these enzymes is
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heavily dependent on the growth of the producer strain at pH of >7.5 [75]. The characteristics of the
extracellular lipases, proteases, and β-glucosidase (cold-active, halotolerant, alkaline-active) produced
by these Pseudoalteromonas strains together with their short doubling time at mesophilic temperatures,
make these isolates an attractive source for further investigation.
5. Materials and Methods
5.1. Sponge Collection and Isolation of Microorganisms
The sponges (Poecillastra compressa, Inflatella pellicula and Sericolophus hawaiicus) used for the
isolation of microorganisms have been collected of the west coast of Ireland during the Biodiscovery
cruises 2010 and 2013 by the remotely operated vehicle Holland I on board the R.V. Celtic Explorer.
The sponges were rinsed directly after collection with sterile artificial sea water (3.33% (w/v) Instant
Ocean, Aquarium Systems) to remove any exogenous material and were subsequently stored at−80 ◦C
until further processing. The isolation of microorganisms was performed as follows; small sponge
pieces were macerated with a sterile razor blade and serially diluted with artificial seawater and plated
onto Starch-Yeast Extract-Peptone Seawater (SYP-SW) plates (10 g/L starch, 4 g/L yeast extract, 2 g/L
peptone, 33.3 g/L artificial sea salt, 1.5% agar). The plates were inspected daily for colonies and
incubated for four weeks at 28 ◦C. All colonies were restreaked until pure cultures were obtained.
5.2. Enzyme Activity Plate Screenings
The pure cultures were tested for different enzyme activities. All screenings were carried out at
28 ◦C and incubated for three to four days.
Protease screening was carried out using SYP-SW plates supplemented with 2% skim milk
(Sigma-Aldrich, Arklow, Ireland), a clear halo around the colonies after incubation indicates a possible
protease activity. Positive colonies were further tested on SYP-SW plates supplemented with 40 ng/mL
X-Gal to differentiate between true protease activity and β-glucosidase/β-galactosidase activity, a blue
colour change of the colony would indicate that it is rather the latter activity.
Cellulase activity was tested using SYP-SW plates supplemented with 0.1% Ostazin brilliant red
hydroxyethyl-cellulose (OBR-HEC; Slovak Academy of Science, Institute of Chemistry); clear halos
around colonies indicate cellulase activity.
Lipase activity was investigated via adding 1% tributyrin (Sigma-Aldrich) to the SYP-SW plates,
again a clear halo around the colonies indicates a lipase or esterase activity.
5.3. Enzyme Assays and Growth Characterization
The β-glucosidase activity of the heterologously expressed enzyme was measured using 5 µg of
protein, 20 µL 0.1 M p-nitrophenyl-β-d glucopyranoside as substrate and 1 mL of 0.1 M potassium
phosphate buffer solution (pH 7.6). The obtained solution was incubated at 23 ◦C for 10 min and the
absorbance at 420 nm was measured subsequently. The temperature and the pH of the potassium
phosphate buffer were varied for the optimal temperature assays (tested were 4 ◦C, 23 ◦C, 28 ◦C,
37 ◦C, 45 ◦C, and 55 ◦C) and the pH dependency assay (tested were pH 4.5, 6.0, 6.6, 7.0, 7.6, 8.0, and
9.0). According to the Beer–Lambert law, the optimal activity of the β-glucosidase was approximately
2.5 U/mg, where one unit of β-glucosidase corresponds to the release of 1 µmol of p-nitrophenyl
min−1 (ε = 1.6 × 104 M−1 cm−1) in the reaction mixture under the assay conditions 28 ◦C and pH 7.6.
Overnight cultures incubated at 28 ◦C and 180 rpm were diluted the next day in 30 mL marine
broth (Difco marine broth 2216) to an optical density at 600 nm of 0.05 and subsequently incubated
at different temperatures (4 ◦C, 23 ◦C, 28 ◦C, 37 ◦C) in shaking incubators. The growth was
monitored hourly by measuring the optical density at 600 nm. The specific growth rate (mu) and
the generation/doubling time (tgen) was calculated using the formula mu = (ln(X1) − ln(X0))/(t1 − t0)
and tgen = (0.693/mu) × 60, with X0 being the optical density at the beginning of the exponential
Mar. Drugs 2017, 15, 184 12 of 17
growth phase (approximate OD600 of 0.15), X1 a time point within the exponential growth phase
(OD600 between 0.15 and 1.0) and t the time passed between X0 and X1 in hours.
5.4. Genomic DNA Isolation and Sequencing
Genomic DNA isolation was carried out by processing a 10 mL overnight culture (SYP-SW
medium, 28 ◦C, 180 rpm), after centrifugation the media was removed and 2 mL lysis buffer (2% SDS,
1% CTAB, 100 mM Tris, 100 mM EDTA, 1.5 M NaCl, pH 8.0) were added and incubated in a water
bath at 70 ◦C with occasional mixing for two hours. The cell lysate was centrifuged until a clear lysate
was obtained, 0.7 volumes of Isopropanol were subsequently added to precipitate the genomic DNA
(30 min, room temperature). After centrifugation, the supernatant was discarded and the obtained
pellet was washed with 70% ethanol, then centrifuged again and after supernatant removal, air dried
and finally resuspended in an appropriate amount of Tris-EDTA buffer (10 mM Tris, 1 mM EDTA,
pH 8.0). DNA quality was assessed by running 5 µL DNA on an agarose gel resulting in a high
molecular weight band. Purity of DNA was measured on a NanoDrop ND-1000 Spectrophotometer
(Thermo Fisher Scientific, Waltham, MA, USA). DNA was quantified with a Qubit dsDNA HS assay
(Thermo Fisher Scientific) prior to preparing genomic libraries with the Nextera XT DNA Library Prep
Kit (Illumina, San Diego, CA, USA) according to the manufacturer’s instructions. Final libraries were
barcoded with Nextera XT indices, assessed on a Bioanalyzer High Sensitivity DNA chip (Agilent
Technologies, Santa Clara, CA, USA) and sequenced together on an Illumina MiSeq platform using
paired-end 300 bp chemistry. Raw sequence data was quality trimmed using Trimmomatic version
0.36 [79], removing short reads and trimming both ends of reads containing low quality bases. Quality
trimmed reads were assembled using SPAdes version 3.7.0 [80] in paired-end mode with default
settings. The genome completeness was assessed using CheckM [81]. Full length 16S rRNA gene
sequences were predicted for the reference strains using RNAmmer [50]. 16S rRNA gene sequences
from the isolates SK18, SK20, and EB27 were obtained using universal 27f/1492r primer for PCR.
(The genomes are deposited in the NCBI database under the accession numbers MTQB00000000,
MTQC00000000, MTQD00000000).
5.5. Cloning, Expression, and Purification of the β-Glucosidase
The full length β-glucosidase was amplified using primers incorporating enzyme restriction sites
and allowing in-frame cloning into the pBAD/mycHIS-A overexpression vector (Invitrogen, Carlsbad,
CA, USA). Forward primer fBETA2 (TATATATCATGACAAAAATATCATTACCATTTAATTCACC)
incorporates a BspHI restriction site (underlined) at the start codon (italics) of the gene. Reverse
primer rBETA2 (ATATATAAGCTTTCTATTTGAGATAAGTGCTTTATAGG) incorporates a HindIII
restriction site replacing the stop codon of the β-glucosidase gene. The amplified PCR product
was digested with BspHI and HindIII, pBAD/mycHis-A was digested with NcoI and HindIII and
subsequently an overnight ligation was carried out at 4 ◦C at a 10:1 ratio insert to plasmid. Two µL of
the ligation reaction were added to 50 µL TOP10 chemically competent cells (ThermoScientific) and
the transformation was carried out according to the manufacturer’s guidelines. The transformation
mixture was plated in different amounts on LB plates containing 50 µg/mL ampicillin, 0.2% arabinose
and 40 mg/mL X-GAL.
The β-glucosidase enzyme was purified from the overnight culture, supplemented with
100 µg/mL ampicillin and 0.02% arabinose, using the HisPur Ni-NTA Resin (Thermo Fisher Scientific).
50 mL of overnight culture was used and centrifuged at 4000× g for 15 min at 4 ◦C. The pellet was
resuspended in 2 mL of Tris-EDTA buffer and 100 µL of lysozyme (10 mg/mL) was added and
incubated at 37 ◦C for 15 min. After this, the obtained solution was subjected to three freeze-thaw
cycles of 15 min each. After this, the lysate was centrifuged at 12,000× g for 30 min at 4 ◦C and
the supernatant was collected. The HisPur Ni-NTA Resin (2 mL) was packed in a column and was
equilibrated with 4 mL of equilibration buffer (20 mM sodium phosphate, 300 mM sodium chloride,
10 mM imidazole, pH 7.4). The protein lysate was mixed with an equal volume of equilibration buffer
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and was loaded twice onto the Nickel-Nitrilotriacetic acid Ni-NTA column. The column was washed
subsequently three times with 4 mL of wash buffer (PBS, 25 mM imidazole, pH 7.4. The bound protein
was eluted with twice with 4 mL of elution buffer (PBS, 250 mM imidazole, pH 7.4). The obtained
protein elute was concentrated using VWR Vivaspin concentrator columns with a molecular weight
cutoff of 10 kDa.
5.6. Genome Analysis and Comparison
The draft genomes were annotated using the RAST pipeline [82–84]. The genomes of
Pseudoalteromonas haloplanktis TAC125 [46] and Pseudoalteromonas sp. SM9913 [21] were used
as reference genomes for comparison and annotated again in the same manner as the newly
isolated Pseudoalteromonas spp. to rule out annotation biases between different software packages.
Genome comparison was carried out by using the BPGA pipeline [49] and manually screening the
genomes for enzymes of industrial interest. The genomes were screened for secondary metabolite gene
clusters using antiSMASH [57–59].
Supplementary Materials: The Supplementary files are available online at www.mdpi.com/1660-3397/15/6/
184/s1.
Acknowledgments: E.B. and S.K. acknowledge the financial support from the BluePharmTrain project (http://
www.benthis.eu/en/bluepharmtrain.htm) funded through the MC-ITN scheme (contract no. 607786). The authors
A.D.W.D., F.O. and S.A.J. acknowledge the financial support from the PharmaSea project (www.pharma-sea.eu)
funded by the EU Seventh Framework Programme (contract no. 312184) and by the Beaufort Marine Research
Award, part of the Sea Change Strategy and the Strategy for Science Technology and Innovation (2006–2012), with
the support of the Marine Institute under the Marine Research Sub-Programme of the National Development
Plan 2007–2013.
Author Contributions: S.A.J., R.J., V.T.M. and A.D.W.D. conceived and designed the study; E.B. performed
primarily the experiments and analyzed the data, S.K. performed the genome sequencing, E.D. and S.F. carried
out enzyme assays. E.B., S.K., S.A.J., F.O. and A.D.W.D. wrote the manuscript.
Conflicts of Interest: The authors declare no conflict of interest. The founding sponsors had no role in the design
of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the
decision to publish the results.
References
1. Gauthier, G.; Gauthier, M.; Christen, R. Phylogenetic analysis of the genera Alteromonas, Shewanella, and
Moritella using genes coding for small-subunit rRNA sequences and division of the genus Alteromonas into
two genera, Alteromonas (emended) and Pseudoalteromonas gen. nov., and proposal of twelve new species
combinations. Int. J. Syst. Bacteriol. 1995, 45, 755–761. [PubMed]
2. Egan, S.; James, S.; Holmström, C.; Kjelleberg, S. Correlation between pigmentation and antifouling
compounds produced by Pseudoalteromonas tunicata. Environ. Microbiol. 2002, 4, 433–442. [CrossRef]
[PubMed]
3. Bowman, J.P. Bioactive compound synthetic capacity and ecological significance of marine bacterial genus
Pseudoalteromonas. Mar. Drugs 2007, 5, 220–241. [CrossRef] [PubMed]
4. Fehér, D.; Barlow, R.; McAtee, J.; Hemscheidt, T.K. Highly brominated antimicrobial metabolites from a
marine Pseudoalteromonas sp. J. Nat. Prod. 2010, 73, 1963–1966. [CrossRef] [PubMed]
5. Holmström, C.; James, S.; Egan, S.; Kjelleberg, S. Inhibition of common fouling organisms by marine bacterial
isolates ith special reference to the role of pigmented bacteria. Biofouling 1996, 10, 251–259. [CrossRef]
[PubMed]
6. Cies´lin´ski, H.; Kur, J.; Białkowska, A.; Baran, I.; Makowski, K.; Turkiewicz, M. Cloning, expression, and
purification of a recombinant cold-adapted beta-galactosidase from antarctic bacterium Pseudoalteromonas sp.
22b. Protein Expr. Purif. 2005, 39, 27–34. [CrossRef] [PubMed]
7. Dobretsov, S.; Xiong, H.; Xu, Y.; Levin, L.A.; Qian, P.Y. Novel antifoulants: Inhibition of larval attachment by
proteases. Mar. Biotechnol. N. Y. 2007, 9, 388–397. [CrossRef] [PubMed]
8. Mo, S.; Kim, J.H.; Cho, K.W. A novel extracellular phospholipase C purified from a marine bacterium,
Pseudoalteromonas sp. J937. Biotechnol. Lett. 2009, 31, 89–94. [CrossRef] [PubMed]
Mar. Drugs 2017, 15, 184 14 of 17
9. Oh, C.; Nikapitiya, C.; Lee, Y.; Whang, I.; Kim, S.J.; Kang, D.H.; Lee, J. Cloning, purification and
biochemical characterization of beta agarase from the marine bacterium Pseudoalteromonas sp. AG4. J.
Ind Microbiol. Biotechnol. 2010, 37, 483–494. [CrossRef] [PubMed]
10. Yan, B.Q.; Chen, X.L.; Hou, X.Y.; He, H.; Zhou, B.C.; Zhang, Y.Z. Molecular analysis of the gene encoding a
cold-adapted halophilic subtilase from deep-sea psychrotolerant bacterium Pseudoalteromonas sp. SM9913:
Cloning, expression, characterization and function analysis of the C-terminal PPC domains. Extremophiles
2009, 13, 725–733. [CrossRef] [PubMed]
11. Holmström, C.; Kjelleberg, S. Marine Pseudoalteromonas species are associated with higher organisms and
produce biologically active extracellular agents. FEMS Microbiol. Ecol. 1999, 30, 285–293. [CrossRef]
12. Holmström, C.; James, S.; Neilan, B.A.; White, D.C.; Kjelleberg, S. Pseudoalteromonas tunicata sp. nov.,
a bacterium that produces antifouling agents. Int. J. Syst. Bacteriol. 1998, 48 Pt 4, 1205–1212. [CrossRef]
[PubMed]
13. Egan, S.; Holmström, C.; Kjelleberg, S. Pseudoalteromonas ulvae sp. nov., a bacterium with antifouling activities
isolated from the surface of a marine alga. Int. J. Syst. Evol. Microbiol. 2001, 51, 1499–1504. [CrossRef]
[PubMed]
14. Ivanova, E.P.; Shevchenko, L.S.; Sawabe, T.; Lysenko, A.M.; Svetashev, V.I.; Gorshkova, N.M.; Satomi, M.;
Christen, R.; Mikhailov, V.V. Pseudoalteromonas maricaloris sp. nov., isolated from an australian sponge, and
reclassification of [Pseudoalteromonas aurantia] NCIMB 2033 as Pseudoalteromonas flavipulchra sp. nov. Int. J.
Syst. Evol. Microbiol. 2002, 52, 263–271. [CrossRef] [PubMed]
15. Ivanova, E.P.; Kiprianova, E.A.; Mikhailov, V.V.; Levanova, G.F.; Garagulya, A.D.; Gorshkova, N.M.;
Vysotskii, M.V.; Nicolau, D.V.; Yumoto, N.; Taguchi, T.; et al. Phenotypic diversity of Pseudoalteromonas citrea
from different marine habitats and emendation of the description. Int. J. Syst. Bacteriol. 1998, 48 Pt 1, 247–256.
[CrossRef] [PubMed]
16. Simidu, U.; Kita-Tsukamoto, K.; Yasumoto, T.; Yotsu, M. Taxonomy of four marine bacterial strains that
produce tetrodotoxin. Int. J. Syst. Bacteriol. 1990, 40, 331–336. [CrossRef] [PubMed]
17. Yoshikawa, K.; Takadera, T.; Adachi, K.; Nishijima, M.; Sano, H. Korormicin, a novel antibiotic specifically
active against marine gram-negative bacteria, produced by a marine bacterium. J. Antibiot. Tokyo 1997, 50,
949–953. [CrossRef] [PubMed]
18. Akagawa-Matsushita, M.; Matsuo, M.; Koga, Y.; Yamasato, K. Alteromonas atlantica sp. nov and Alteromonas
carrageenovora sp. nov., bacteria that decompose algal polysaccharides. Int. J. Syst. Evol. Microbiol. 1992, 42,
621–627. [CrossRef]
19. Bozal, N.; Tudela, E.; Rosselló-Mora, R.; Lalucat, J.; Guinea, J. Pseudoalteromonas antarctica sp. nov., isolated
from an antarctic coastal environment. Int. J. Syst. Bacteriol. 1997, 47, 345–351. [CrossRef] [PubMed]
20. Bowman, J.P. Pseudoalteromonas prydzensis sp. nov., a psychrotrophic, halotolerant bacterium form antarctic
sea ice. Int. J. Syst. Bacteriol. 1998, 48 Pt 3, 1037–1041. [CrossRef] [PubMed]
21. Qin, Q.L.; Li, Y.; Zhang, Y.J.; Zhou, Z.M.; Zhang, W.X.; Chen, X.L.; Zhang, X.Y.; Zhou, B.C.; Wang, L.;
Zhang, Y.Z. Comparative genomics reveals a deep-sea sediment-adapted life style of Pseudoalteromonas sp.
SM9913. ISME J. 2011, 5, 274–284. [CrossRef] [PubMed]
22. Ramirez-Llodra, E.; Brandt, A.; Danovaro, R.; De Mol, B.; Escobar, E.; German, C.; Levin, L.; Arbizu, P.;
Menot, L.; Buhl-Mortensen, P. Deep, diverse and definitely different: Unique attributes of the world’s largest
ecosystem. Biogeosciences 2010, 7, 2851–2899. [CrossRef]
23. Sipkema, D. Marine biotechnology: Diving deeper for drugs. Microb. Biotechnol. 2016. [CrossRef] [PubMed]
24. Borchert, E.; Jackson, S.A.; O’Gara, F.; Dobson, A.D. Diversity of natural product biosynthetic genes in
the microbiome of the deep sea sponges Inflatella pellicula, Poecillastra compressa, and Stelletta normani.
Front. Microbiol. 2016, 7, 1027. [CrossRef] [PubMed]
25. Jackson, S.A.; Flemer, B.; McCann, A.; Kennedy, J.; Morrissey, J.P.; O’Gara, F.; Dobson, A.D. Archaea appear
to dominate the microbiome of Inflatella pellicula deep sea sponges. PLoS ONE 2013, 8, e84438. [CrossRef]
[PubMed]
26. Kennedy, J.; Flemer, B.; Jackson, S.A.; Morrissey, J.P.; O’Gara, F.; Dobson, A.D. Evidence of a putative deep
sea specific microbiome in marine sponges. PLoS ONE 2014, 9, e91092. [CrossRef] [PubMed]
27. Xu, W.; Pang, K.L.; Luo, Z.H. High fungal diversity and abundance recovered in the deep-sea sediments of
the Pacific Ocean. Microb. Ecol. 2014, 68, 688–698. [CrossRef] [PubMed]
Mar. Drugs 2017, 15, 184 15 of 17
28. Li, X.D.; Li, X.M.; Li, X.; Xu, G.M.; Liu, Y.; Wang, B.G. Aspewentins D-H, 20-Nor-isopimarane derivatives from
the deep sea sediment-derived fungus Aspergillus wentii SD-310. J. Nat. Prod. 2016, 79, 1347–1353. [CrossRef]
[PubMed]
29. Wu, B.; Wiese, J.; Schmaljohann, R.; Imhoff, J.F. Biscogniauxone, a new isopyrrolonaphthoquinone compound
from the fungus Biscogniauxia mediterranea isolated from deep-sea sediments. Mar. Drugs 2016, 14, 204.
[CrossRef] [PubMed]
30. Shao, X.; Ran, L.Y.; Liu, C.; Chen, X.L.; Zhang, X.Y.; Qin, Q.L.; Zhou, B.C.; Zhang, Y.Z. Culture condition
optimization and pilot scale production of the M12 metalloprotease Myroilysin produced by the deep-sea
bacterium myroides profundi D25. Molecules 2015, 20, 11891–11901. [CrossRef] [PubMed]
31. Yang, J.; Yu, Y.; Tang, B.L.; Zhong, S.; Shi, M.; Xie, B.B.; Zhang, X.Y.; Zhou, B.C.; Zhang, Y.Z.; Chen, X.L.
Pilot-scale production and thermostability improvement of the M23 protease pseudoalterin from the deep
sea bacterium Pseudoalteromonas sp. CF6-2. Molecules 2016, 21, 1567. [CrossRef] [PubMed]
32. Cavicchioli, R.; Siddiqui, K.S.; Andrews, D.; Sowers, K.R. Low-temperature extremophiles and their
applications. Curr. Opin. Biotechnol. 2002, 13, 253–261. [CrossRef]
33. Santiago, M.; Ramírez-Sarmiento, C.A.; Zamora, R.A.; Parra, L.P. Discovery, molecular mechanisms, and
industrial applications of cold-active enzymes. Front. Microbiol. 2016, 7, 1408. [CrossRef] [PubMed]
34. Georlette, D.; Jónsson, Z.O.; Van Petegem, F.; Chessa, J.; Van Beeumen, J.; Hübscher, U.; Gerday, C. A DNA
ligase from the psychrophile Pseudoalteromonas haloplanktis gives insights into the adaptation of proteins to
low temperatures. Eur J. Biochem. 2000, 267, 3502–3512. [CrossRef] [PubMed]
35. Albino, A.; De Angelis, A.; Marco, S.; Severino, V.; Chambery, A.; Di Maro, A.; Desiderio, D.; Raimo, G.;
Masullo, M.; De Vendittis, E. The cold-adapted γ-glutamyl-cysteine ligase from the psychrophile
Pseudoalteromonas haloplanktis. Biochimie 2014, 104, 50–60. [CrossRef] [PubMed]
36. Truong, L.V.; Tuyen, H.; Helmke, E.; Binh, L.T.; Schweder, T. Cloning of two pectate lyase genes from
the Marine antarctic bacterium Pseudoalteromonas haloplanktis strain ANT/505 and characterization of the
enzymes. Extremophiles 2001, 5, 35–44. [CrossRef] [PubMed]
37. Cotugno, R.; Rosaria Ruocco, M.; Marco, S.; Falasca, P.; Evangelista, G.; Raimo, G.; Chambery, A.; Di Maro, A.;
Masullo, M.; De Vendittis, E. Differential cold-adaptation among protein components of the thioredoxin
system in the psychrophilic eubacterium Pseudoalteromonas haloplanktis TAC 125. Mol. Biosyst. 2009, 5,
519–528. [CrossRef] [PubMed]
38. Falasca, P.; Evangelista, G.; Cotugno, R.; Marco, S.; Masullo, M.; De Vendittis, E.; Raimo, G. Properties of
the endogenous components of the thioredoxin system in the psychrophilic eubacterium Pseudoalteromonas
haloplanktis TAC 125. Extremophiles 2012, 16, 539–552. [CrossRef] [PubMed]
39. Castellano, I.; Di Maro, A.; Ruocco, M.R.; Chambery, A.; Parente, A.; Di Martino, M.T.; Parlato, G.;
Masullo, M.; De Vendittis, E. Psychrophilic superoxide dismutase from Pseudoalteromonas haloplanktis:
Biochemical characterization and identification of a highly reactive cysteine residue. Biochimie 2006, 88,
1377–1389. [CrossRef] [PubMed]
40. Castellano, I.; Ruocco, M.R.; Cecere, F.; Di Maro, A.; Chambery, A.; Michniewicz, A.; Parlato, G.; Masullo, M.;
De Vendittis, E. Glutathionylation of the iron superoxide dismutase from the psychrophilic eubacterium
Pseudoalteromonas haloplanktis. Biochem. Biophys. Acta 2008, 1784, 816–826. [CrossRef] [PubMed]
41. Pulicherla, K.K.; Sambasiva Rao, K.R.S. Marine biocatalysts and their stability: Molecular approach. In Marine
Enzymes for Biocatalysis—Sources, Biocatalytic Characteristics and Bioprocesses of Marine Enzymes; Trincone, A.,
Ed.; Woodhead Publishing Series in Biomedicine: Cambridge, UK, 2013; pp. 109–130.
42. Xie, B.B.; Shu, Y.L.; Qin, Q.L.; Rong, J.C.; Zhang, X.Y.; Chen, X.L.; Zhou, B.C.; Zhang, Y.Z. Genome sequence
of the cycloprodigiosin-producing bacterial strain Pseudoalteromonas rubra ATCC 29570(T). J. Bacteriol. 2012,
194, 1637–1638. [CrossRef] [PubMed]
43. Bosi, E.; Fondi, M.; Orlandini, V.; Perrin, E.; Maida, I.; de Pascale, D.; Tutino, M.L.; Parrilli, E.; Lo Giudice, A.;
Filloux, A.; et al. The pan-genome of (Antarctic) Pseudoalteromonas bacteria: Evolutionary and functional
insights. BMC Genom. 2017, 18, 93. [CrossRef] [PubMed]
44. Isnansetyo, A.; Kamei, Y. Mc21-A, a bactericidal antibiotic produced by a new marine bacterium,
Pseudoalteromonas phenolica sp. nov. O-BC30(T), against methicillin-resistant Staphylococcus aureus. Antimicrob.
Agents Chemother. 2003, 47, 480–488. [CrossRef] [PubMed]
Mar. Drugs 2017, 15, 184 16 of 17
45. Sannino, F.; Parrilli, E.; Apuzzo, G.A.; de Pascale, D.; Tedesco, P.; Maida, I.; Perrin, E.; Fondi, M.; Fani, R.;
Marino, G.; et al. Pseudoalteromonas haloplanktis produces methylamine, a volatile compound active against
Burkholderia cepacia complex strains. New Biotechnol. 2017, 35, 13–18. [CrossRef] [PubMed]
46. Médigue, C.; Krin, E.; Pascal, G.; Barbe, V.; Bernsel, A.; Bertin, P.N.; Cheung, F.; Cruveiller, S.; D’Amico, S.;
Duilio, A.; et al. Coping with cold: The genome of the versatile marine Antarctica bacterium Pseudoalteromonas
haloplanktis TAC125. Genome Res. 2005, 15, 1325–1335. [CrossRef] [PubMed]
47. Grigoriev, I.V.; Nordberg, H.; Shabalov, I.; Aerts, A.; Cantor, M.; Goodstein, D.; Kuo, A.; Minovitsky, S.;
Nikitin, R.; Ohm, R.A.; et al. The genome portal of the department of energy joint genome institute. Nucleic
Acids Res. 2012, 40, D26–D32. [CrossRef] [PubMed]
48. Nordberg, H.; Cantor, M.; Dusheyko, S.; Hua, S.; Poliakov, A.; Shabalov, I.; Smirnova, T.; Grigoriev, I.V.;
Dubchak, I. The genome portal of the department of energy joint genome institute: 2014 updates.
Nucleic Acids Res. 2014, 42, D26–D31. [CrossRef] [PubMed]
49. Chaudhari, N.M.; Gupta, V.K.; Dutta, C. Bpga—An ultra-fast pan-genome analysis pipeline. Sci. Rep. 2016,
6, 24373. [CrossRef] [PubMed]
50. Lagesen, K.; Hallin, P.; Rødland, E.A.; Staerfeldt, H.H.; Rognes, T.; Ussery, D.W. Rnammer: Consistent and
rapid annotation of ribosomal RNA genes. Nucleic Acids Res. 2007, 35, 3100–3108. [CrossRef] [PubMed]
51. Fan, L.; Reynolds, D.; Liu, M.; Stark, M.; Kjelleberg, S.; Webster, N.S.; Thomas, T. Functional equivalence
and evolutionary convergence in complex communities of microbial sponge symbionts. Proc. Natl. Acad.
Sci. USA 2012, 109, E1878–E1887. [CrossRef] [PubMed]
52. Bardou, P.; Mariette, J.; Escudié, F.; Djemiel, C.; Klopp, C. Jvenn: An interactive Venn diagram viewer.
BMC Bioinform. 2014, 15, 293. [CrossRef] [PubMed]
53. Tamura, K.; Stecher, G.; Peterson, D.; Filipski, A.; Kumar, S. MEGA6: Molecular evolutionary genetics
analysis version 6.0. Mol. Biol. Evol. 2013, 30, 2725–2729. [CrossRef] [PubMed]
54. Letunic, I.; Bork, P. Interactive Tree Of Life (itol): An online tool for phylogenetic tree display and annotation.
Bioinformatics 2007, 23, 127–128. [CrossRef] [PubMed]
55. Letunic, I.; Bork, P. Interactive Tree Of Life v2: Online annotation and display of phylogenetic trees made
easy. Nucleic Acids Res. 2011, 39, W475–W478. [CrossRef] [PubMed]
56. Medini, D.; Donati, C.; Tettelin, H.; Masignani, V.; Rappuoli, R. The microbial pan-genome. Curr. Opin.
Genet. Dev. 2005, 15, 589–594. [CrossRef] [PubMed]
57. Blin, K.; Medema, M.H.; Kazempour, D.; Fischbach, M.A.; Breitling, R.; Takano, E.; Weber, T. Antismash
2.0—A versatile platform for genome mining of secondary metabolite producers. Nucleic Acids Res. 2013, 41,
W204–W212. [CrossRef] [PubMed]
58. Medema, M.H.; Blin, K.; Cimermancic, P.; de Jager, V.; Zakrzewski, P.; Fischbach, M.A.; Weber, T.; Takano, E.;
Breitling, R. Antismash: Rapid identification, annotation and analysis of secondary metabolite biosynthesis
gene clusters in bacterial and fungal genome sequences. Nucleic Acids Res. 2011, 39, W339–W346. [CrossRef]
[PubMed]
59. Weber, T.; Blin, K.; Duddela, S.; Krug, D.; Kim, H.U.; Bruccoleri, R.; Lee, S.Y.; Fischbach, M.A.; Müller, R.;
Wohlleben, W.; et al. Antismash 3.0—A comprehensive resource for the genome mining of biosynthetic gene
clusters. Nucleic Acids Res. 2015, 43, W237–W243. [CrossRef] [PubMed]
60. Reynolds, D.; Thomas, T. Evolution and function of eukaryotic-like proteins from sponge symbionts. Mol.
Ecol. 2016, 25, 5242–5253. [CrossRef] [PubMed]
61. Siegl, A.; Kamke, J.; Hochmuth, T.; Piel, J.; Richter, M.; Liang, C.; Dandekar, T.; Hentschel, U. Single-cell
genomics reveals the lifestyle of Poribacteria, a candidate phylum symbiotically associated with marine
sponges. ISME J. 2011, 5, 61–70. [CrossRef] [PubMed]
62. Lee, S.O.; Kato, J.; Nakashima, K.; Kuroda, A.; Ikeda, T.; Takiguchi, N.; Ohtake, H. Cloning and
characterization of extracellular metal protease gene of the algicidal marine bacterium Pseudoalteromonas sp.
Strain A28. Biosci. Biotechnol. Biochem. 2002, 66, 1366–1369. [CrossRef] [PubMed]
63. Bartlett, D.H.; Wright, M.E.; Silverman, M. Variable expression of extracellular polysaccharide in the marine
bacterium Pseudomonas atlantica is controlled by genome rearrangement. Proc. Natl. Acad. Sci. USA 1988, 85,
3923–3927. [CrossRef] [PubMed]
64. Longeon, A.; Peduzzi, J.; Barthélemy, M.; Corre, S.; Nicolas, J.L.; Guyot, M. Purification and partial
identification of novel antimicrobial protein from marine bacterium Pseudoalteromonas species strain X153.
Mar. Biotechnol. N. Y. 2004, 6, 633–641. [CrossRef] [PubMed]
Mar. Drugs 2017, 15, 184 17 of 17
65. Zhang, X.; Enomoto, K. Characterization of a gene cluster and its putative promoter region for violacein
biosynthesis in Pseudoalteromonas sp. 520P1. Appl. Microbiol. Biotechnol. 2011, 90, 1963–1971. [CrossRef]
[PubMed]
66. Sezonov, G.; Joseleau-Petit, D.; D’Ari, R. Escherichia coli physiology in luria-bertani broth. J. Bacteriol. 2007,
189, 8746–8749. [CrossRef] [PubMed]
67. Papa, R.; Rippa, V.; Sannia, G.; Marino, G.; Duilio, A. An effective cold inducible expression system developed
in Pseudoalteromonas haloplanktis tac125. J. Biotechnol. 2007, 127, 199–210. [CrossRef] [PubMed]
68. Sørensen, A.; Lübeck, M.; Lübeck, P.S.; Ahring, B.K. Fungal beta-glucosidases: A bottleneck in industrial use
of lignocellulosic materials. Biomolecules 2013, 3, 612–631. [CrossRef] [PubMed]
69. Singh, G.; Verma, A.K.; Kumar, V. Catalytic properties, functional attributes and industrial applications of
β-glucosidases. 3 Biotech 2016, 6, 3. [CrossRef] [PubMed]
70. Matsumoto, M.; Yokouchi, H.; Suzuki, N.; Ohata, H.; Matsunaga, T. Saccharification of marine microalgae
using marine bacteria for ethanol production. Appl. Biochem. Biotechnol. 2003, 105, 247–254. [CrossRef]
71. El-Naggar, M.M.; Abdul-Raouf, U.M.; Ibrahim, H.A.; El-Sayed, W.M. Saccharification of ulva lactuca via
Pseudoalteromonas piscicida for biofuel production. J. Energy Natl. Resour. 2014, 3, 77–84.
72. Offret, C.; Desriac, F.; Le Chevalier, P.; Mounier, J.; Jégou, C.; Fleury, Y. Spotlight on antimicrobial metabolites
from the marine bacteria Pseudoalteromonas: Chemodiversity and ecological significance. Mar. Drugs 2016,
14, 129. [CrossRef] [PubMed]
73. Kamke, J.; Bayer, K.; Woyke, T.; Hentschel, U. Exploring symbioses by single-cell genomics. Biol. Bull. 2012,
223, 30–43. [CrossRef] [PubMed]
74. Shikuma, N.J.; Pilhofer, M.; Weiss, G.L.; Hadfield, M.G.; Jensen, G.J.; Newman, D.K. Marine tubeworm
metamorphosis induced by arrays of bacterial phage tail-like structures. Science 2014, 343, 529–533.
[CrossRef] [PubMed]
75. Shirazian, P.; Asad, S.; Amoozegar, M. The potential of halotolerant bacteria for the production of
antineoplastic enzymes: L-asparaginase and L-glutaminase. Excli J. 2016, 15, 268–279. [PubMed]
76. Cavicchioli, R.; Charlton, T.; Ertan, H.; Mohd Omar, S.; Siddiqui, K.S.; Williams, T.J. Biotechnological uses of
enzymes from psychrophiles. Microb. Biotechnol. 2011, 4, 449–460. [CrossRef] [PubMed]
77. Bhatia, Y.; Mishra, S.; Bisaria, V.S. Microbial β-glucosidases: Cloning, properties and applications. Crit. Rev.
Biotechnol. 2002, 22, 375–407.
78. Market Reports Hub. Available online: http://www.marketreportshub.com/proteases-industry-research-
marketsandmarkets.html (accessed on 8 June 2017).
79. Bolger, A.M.; Lohse, M.; Usadel, B. Trimmomatic: A flexible trimmer for illumina sequence data.
Bioinformatics 2014, 30, 2114–2120. [CrossRef] [PubMed]
80. Bankevich, A.; Nurk, S.; Antipov, D.; Gurevich, A.A.; Dvorkin, M.; Kulikov, A.S.; Lesin, V.M.; Nikolenko, S.I.;
Pham, S.; Prjibelski, A.D.; et al. Spades: A new genome assembly algorithm and its applications to single-cell
sequencing. J. Comput. Biol. 2012, 19, 455–477. [CrossRef] [PubMed]
81. Parks, D.H.; Imelfort, M.; Skennerton, C.T.; Hugenholtz, P.; Tyson, G.W. Checkm: Assessing the quality of
microbial genomes recovered from isolates, single cells, and metagenomes. Genome Res. 2015, 25, 1043–1055.
[CrossRef] [PubMed]
82. Aziz, R.K.; Bartels, D.; Best, A.A.; DeJongh, M.; Disz, T.; Edwards, R.A.; Formsma, K.; Gerdes, S.; Glass, E.M.;
Kubal, M.; et al. The rast server: Rapid annotations using subsystems technology. BMC Genom. 2008, 9, 75.
[CrossRef] [PubMed]
83. Brettin, T.; Davis, J.J.; Disz, T.; Edwards, R.A.; Gerdes, S.; Olsen, G.J.; Olson, R.; Overbeek, R.; Parrello, B.;
Pusch, G.D.; et al. Rasttk: A modular and extensible implementation of the RAST algorithm for building
custom annotation pipelines and annotating batches of genomes. Sci. Rep. 2015, 5, 8365. [CrossRef] [PubMed]
84. Overbeek, R.; Olson, R.; Pusch, G.D.; Olsen, G.J.; Davis, J.J.; Disz, T.; Edwards, R.A.; Gerdes, S.; Parrello, B.;
Shukla, M.; et al. The seed and the rapid annotation of microbial genomes using subsystems technology
(RAST). Nucleic Acids Res. 2014, 42, D206–D214. [CrossRef] [PubMed]
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
